Nurgul Aytan

Nurgul Aytan

Auto-generated profile, based on publicly available information

Nurgul Aytan

Department of Veterans Affairs, VA Boston Healthcare System, 150 S Huntington Av., Boston, MA 02130, USA; Department of Neurology, Boston University School of Medicine, 72 E Concord St., Boston, MA 02118, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Experimental Neurology
Verified
Journal Article
Closed access
AKAlpdogan Kantarci
Alpdogan Kantarci
NANurgul Aytan
Nurgul Aytan
IPIro Palaska
Iro Palaska
DSDanielle Stephens
Danielle Stephens
LCLeah Crabtree
Leah Crabtree
ADAlpaslan Dedeoglu
Alpaslan Dedeoglu

1 June 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
NANurgul Aytan
Nurgul Aytan
JCJi-Kyung Choi
Ji-Kyung Choi
ICIsabel Carreras
Isabel Carreras
LCLeah Crabtree
Leah Crabtree
BNBrian Nguyen
Brian Nguyen
ADAlpaslan Dedeoglu
Alpaslan Dedeoglu

1 December 2013 in Experimental Neurology
Verified
Journal Article
Closed access
NANurgul Aytan
Nurgul Aytan
JCJi-Kyung Choi
Ji-Kyung Choi
ICIsabel Carreras
Isabel Carreras
NKNeil W. Kowall
Neil W. Kowall
BJBruce G. Jenkins
Bruce G. Jenkins
ADAlpaslan Dedeoglu
Alpaslan Dedeoglu

1 February 2018 in Brain Research
Verified
Journal Article
Closed access
ICIsabel Carreras
Isabel Carreras
NANurgul Aytan
Nurgul Aytan
TMTiffany Mellott
Tiffany Mellott
JCJi-Kyung Choi
Ji-Kyung Choi
MLMargaret Lehar
Margaret Lehar
ADAlpaslan Dedeoglu
Alpaslan Dedeoglu

1 January 2016 in Surgical Neurology International
Verified
Journal Article
Open access
MSMehdi Sasani
Mehdi Sasani
AAAhmetLevent Aydin
AhmetLevent Aydin
NANurgul Aytan
Nurgul Aytan
OYOzlem Yapicier
Ozlem Yapicier
TOTunc Oktenoglu
Tunc Oktenoglu
Ali Fahir OzerAli Fahir Ozer
Ali Fahir Ozer
To identify the role of the hypercholesterolemia as a starting factor in discovertebral degeneration that ultimately causes lower back pain, and investigate the role of Vitamin E in this process. The rabbits (n = 32) were divided into two broad experimental groups: A control group, and a hypercholesterolemia group, namely cholesterol, and cholesterol plus Vitamin E groups and they were fed sequentially for 4 or 8 weeks. Serum cholesterol and Vitamin E (α-tocopherol) levels were determined; vascular tissue was prepared for histopathological analyses and vertebra was decalcified for the study. Cholesterol diet group resulted approximately 44-fold of increase plasma cholesterol levels over the 4-week control values. Additional supplementation with Vitamin E group induced a plasma cholesterol level increase of only 37-fold as compared to the control group. In the cholesterol groups, light microscope examination revealed atherosclerotic plaque in major arteries. However, in the cholesterol plus Vitamin E treatment groups, no lipid accumulation or foam cell formation was visible in the abdominal aorta and vertebral segmental artery. In histopathological examination, we found degenerative changes in the discovertebral unit in cholesterol treated groups. Hypercholesterolemia causes fat accumulation in the disc endplate and vertebral body that causes blood supply disturbances which might be a starting factor of discovertebral degeneration. This event was not reversed by the elimination of cholesterol from the diet. Vitamin E supplementation was not effective in reducing fat accumulation in vertebral bone marrow. As a result, we conclude that degeneration of the discovertebral unit is not related to atherosclerotic changes in the major blood vessels.